help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cittadini, A.
Right arrow Articles by Saccà, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cittadini, A.
Right arrow Articles by Saccà, L.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 4 1654-1659
Copyright © 2002 by The Endocrine Society


Other Original Articles

Supraphysiological Doses of GH Induce Rapid Changes in Cardiac Morphology and Function

Antonio Cittadini, Annika Berggren, Salvatore Longobardi, Christer Ehrnborg, Raffaele Napoli, Thord Rosén, Serafino Fazio, Kenneth Caidahl, Bengt-Åke Bengtsson and Luigi Saccà

Department of Internal Medicine and Cardiovascular Sciences (A.C., S.L., R.N., S.F., K.C., L.S.), Federico II University, 80131 Naples, Italy; and Department of Medicine (A.B., C.E., T.R., B.-Å.B.), Sahlgrenska University, SE-41345 Gothenberg, Sweden

Address all correspondence and requests for reprints to: Luigi Saccà, M.D., Department of Internal Medicine and Cardiovascular Sciences, Via Sergio Pansini 5, 80131 Naples, Italy. E-mail: . sacca{at}unina.it

Abstract

GH is an agent widely used in sport to improve physical performance and has been proposed as adjunctive therapy in several clinical conditions. However, its short-term effects on the normal human heart are poorly understood.

Sixty young normal volunteers (30 males and 30 females) were enrolled in a multicenter, double-blind, placebo-controlled study. All subjects were randomized to receive GH (0.03 or 0.06 mg/kg·d) or placebo. A complete Doppler-echocardiographic examination was performed at baseline and after 4 wk of treatment.

Low-dose GH did not significantly affect echocardiographic parameters. In contrast, high-dose GH increased left ventricular mass index by 12% (P < 0.05). The type of growth response was concentric, because left ventricular wall thickness but not diameter increased, leading to a 10% increase of relative wall thickness. These structural changes were associated with functional changes, including a significant increase in cardiac index and a decrease in peripheral vascular resistance; diastolic function was not altered. Fractional shortening and systemic blood pressure were unchanged in the two treatment groups.

In conclusion, administration of GH for 4 wk at doses that simulate GH abuse in sport caused a high cardiac output state associated with concentric left ventricular remodeling.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. G. Giannoulis, N. Jackson, F. Shojaee-Moradie, K. S. Nair, P. H. Sonksen, F. C. Martin, and A. M. Umpleby
The Effects of Growth Hormone and/or Testosterone on Whole Body Protein Kinetics and Skeletal Muscle Gene Expression in Healthy Elderly Men: A Randomized Controlled Trial
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3066 - 3074.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. van den Berg, E. M. N. Bannink, P. A. Wielopolski, W. C. J. Hop, L. van Osch-Gevers, P. M. T. Pattynama, S. M. P. F. de Muinck Keizer-Schrama, and W. A. Helbing
Cardiac Status after Childhood Growth Hormone Treatment of Turner Syndrome
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2553 - 2558.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
H. Liu, D. M. Bravata, I. Olkin, A. Friedlander, V. Liu, B. Roberts, E. Bendavid, O. Saynina, S. R. Salpeter, A. M. Garber, et al.
Systematic Review: The Effects of Growth Hormone on Athletic Performance
Ann Intern Med, May 20, 2008; 148(10): 747 - 758.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
F. Bogazzi, F. Raggi, F. Ultimieri, D. Russo, A. Manariti, A. D'Alessio, P. Viacava, G. Fanelli, M. Gasperi, L. Bartalena, et al.
Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH
J. Endocrinol., September 1, 2007; 194(3): 521 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Bondy, P. L. Van, V. K. Bakalov, and V. B. Ho
Growth Hormone Treatment and Aortic Dimensions in Turner Syndrome
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1785 - 1788.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society